The Trump administration is seeking to restrict American investment in Chinese biotechnology companies, potentially complicating financial ties at a time when US drugmakers are increasingly turning to China for new medicines.
The Trump administration is seeking to restrict American investment in Chinese biotechnology companies, potentially complicating financial ties at a time when US drugmakers are increasingly turning to China for new medicines.
<iframe src="https://statesidedaily.com/embed/cluster/20b8884556c16bdba6c23d83a1126fe8bea540df" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="US Proposes Curbs on Investment in Chinese Biotech Firms"></iframe>
